Cardiology News

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL’s CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL’s Board of Directors. “As a global leader in medical technology, ZOLL is continually looking for ways to expand our busines...

SAN DIEGO--(BUSINESS WIRE)--Locumpedia named Alain Raymond, PA-C, a cardiothoracic surgical physician assistant with Aya Locums and a U.S. Navy veteran, as a “2025 Locum Tenens Providers of the Year.” This award celebrates the dedication, excellence and impact of locum tenens physicians and advanced practice providers (APPs) across the United States, honoring healthcare providers who deliver high-quality patient care on an as-needed basis to communities in need. After transitioning from frontli...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of results from the U.S. Early Feasibility Study (“EFS”) evaluating ultralow temperature cardiac ablation (“ULTC”) for the treatment of scar-related ventricular tachycardia (“VT”). The study was published in Circulation: Arrythmia and Electrophysiology. The p...

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular completes enrollment in a pivotal trial of its Vertex system with Transforming Fixation technology for pulmonary embolectomy....

WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AFTX-201, an investigational genetic medicine for the treatment of BAG3 DCM. “We are grateful to the FDA for the timel...

IRVING, Texas--(BUSINESS WIRE)--The 2026 Innovative Technology Exchange will take place in September in Las Vegas during the Vizient Connections Summit. Deadline to apply is April 17...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--CardioFocus Announces Late-Breaking Data at AF Symposium 2026 and Expands Pulsed Field Ablation Clinical Programs...

TEL AVIV, Israel--(BUSINESS WIRE)--Endospan, a privately held company pioneering solutions for the endovascular repair of aortic arch disease, today announced the one-year results of their TRIOMPHE Investigational Device Exemption (IDE) Study evaluating the NEXUS® Aortic Arch Stent-Graft System presented during the Society of Thoracic Surgeons (STS) Annual Meeting in New Orleans. TRIOMPHE is a prospective, multicenter, three-arm trial designed to assess the safety and effectiveness of the NEXUS...

FERNANDINA BEACH, Fla.--(BUSINESS WIRE)--Former NFL quarterback, Matt Hasselbeck, and the Family Heart Foundation team up to raise awareness of high cholesterol as a risk for heart disease....

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced it will convene leading cardiovascular physicians and researchers at its third Cardiovascular Scientific Forum, as the Company advances multiple cardiovascular programs following recent FDA regulatory milestones into active clinical engagemen...